CJC-1295 + Ipamorelin 50mg — Vial Spec, Reconstitution Math & COA

Overview of CJC-1295 + Ipamorelin 50mg Specifications

In high-throughput laboratory settings, a 50mg vial specification of CJC-1295 combined with Ipamorelin represents a high-density, multi-dose research compound. Typically formulated in an equal mass ratio (e.g., 25mg CJC-1295 and 25mg Ipamorelin) or custom research ratios, this mass specification is engineered for high-volume in vitro screenings, extended rodent cohort studies, or automated micro-pipetting assays. Ordering high-mass vials minimizes lot-to-lot variability across lengthy experimental timelines while drastically reducing packaging footprint and reconstitution steps in the lab.

It is important to note current catalog availability: while high-capacity 50mg specifications serve institutional or custom synthesis protocols, PX1 Research provides standardized inventory in optimized research sizes, such as our CJC-1295 No DAC + Ipamorelin 10mg Blend. Whether utilizing standard catalog units or analyzing high-mass custom preparations, researchers must apply rigorous reconstitution math and storage controls to preserve biological activity across the duration of their research.

Dual-Pathway Secretagogue Mechanism: GHRH and Ghrelin Receptor Synergy

CJC-1295 functions primarily as a growth-hormone-releasing hormone (GHRH) analog. In preclinical models, it has been studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream IGF-1 levels for tissue repair research. By binding selectively to the GHRH receptor (GHRHR) on anterior pituitary somatotrophs, CJC-1295 stimulates the transcription and pulsatile secretion of endogenous growth hormone without disrupting natural negative feedback loops.

Ipamorelin acts through a distinct, complementary pathway as a selective growth hormone secretagogue receptor (GHSR-1a) agonist, mimicking the action of ghrelin. When administered in combination during in vitro assays, CJC-1295 and Ipamorelin demonstrate a synergistic amplification of GH release. GHRH receptor activation increases intracellular cAMP levels, while GHSR-1a stimulation elevates intracellular calcium ions. Preclinical studies suggest that co-activation of these two independent signal transduction pathways produces a significantly greater release of GH than either compound tested in isolation, making this dual-peptide combination a primary tool for investigating tissue regeneration and protein synthesis markers.

Reconstitution Math for 50mg High-Mass Vials

Reconstituting a 50mg lyophilized cake requires deliberate volume calculations to achieve manageable working concentrations. Because 50mg is a substantial mass of active peptide, adding low volumes of diluent results in highly concentrated solutions that require precise micro-pipetting. Researchers should utilize sterile Bacteriostatic Water (0.9% benzyl alcohol) to maintain microbial control during extended research periods.

Below are standard concentration outputs based on common diluent additions for a total 50mg active mass vial: - **1.0 mL Diluent Added:** Yields a concentration of 50.0 mg/mL (50.0 µg/µL). - **2.0 mL Diluent Added:** Yields a concentration of 25.0 mg/mL (25.0 µg/µL). - **3.0 mL Diluent Added:** Yields a concentration of 16.67 mg/mL (16.67 µg/µL). - **5.0 mL Diluent Added:** Yields a concentration of 10.0 mg/mL (10.0 µg/µL).

When performing complex volumetric calculations involving custom blend ratios, investigators should consult our interactive reconstitution calculator to verify dilution factors and micro-liter delivery volumes prior to assay execution.

Aliquot Planning and Degradation Prevention

Due to the high peptide mass present in a 50mg vial, drawing repeated samples from a single primary container over weeks or months introduces significant risk of solution degradation and bacterial contamination. Repeated needle punctures degrade the stopper seal and expose the dissolved peptide complex to oxygen and thermal fluctuations.

To safeguard structural stability, laboratories should establish an aliquot workflow immediately following initial reconstitution. Under laminar flow, divide the master solution into sterile, polypropylene micro-centrifuge tubes at working volumes single-use size for specific assay runs. Freeze reserve aliquots at -20°C or -80°C. Avoiding repeated freeze-thaw cycles prevents peptide aggregation, peptide bond cleavage, and loss of receptor binding affinity over time.

Storage, Stability, and Temperature Control Protocols

Lyophilized CJC-1295 + Ipamorelin cakes exhibit high thermal stability when stored in desiccated conditions protected from direct light. For short-term transit, un-reconstituted vials remain stable at room temperature; however, upon receipt in the laboratory, lyophilized vials should be transferred to -20°C storage for up to 24 months.

Once reconstituted with bacteriostatic water, liquid solutions must be maintained at refrigerated temperatures (2°C to 8°C) and used within 21 to 28 days. Liquid aliquots stored at -20°C remain stable for several months, while deep freezing at -80°C is recommended for multi-month baseline holds. Exposure to elevated temperatures, ambient UV light, or vigorous mechanical agitation (such as vortexing) can disrupt secondary peptide structures and reduce assay reproducibility.

Analytical Verification and COA Standards for Bulk Blends

Maintaining rigorous quantitative standards requires independent batch verification. PX1 Research mandates that every fill size—from standard 10mg vials to high-density research lots—undergoes comprehensive analytical validation at an independent ISO 17025 accredited laboratory prior to release.

Purity is verified via High-Performance Liquid Chromatography (HPLC), ensuring chemical integrity exceeds 99.0%. Mass identity is confirmed through Mass Spectrometry (MS) to verify molecular weight against theoretical specifications. Crucially, all research blends are subjected to Kinetic Chromogenic LAL testing to confirm endotoxin levels remain strictly below <0.05 EU/mg, preventing false positive inflammatory responses in sensitive cell lines or animal tissue models. Researchers can review lot-specific test results in our transparent COA directory.

Comparative Analysis: High-Capacity 50mg Vials vs. Standard Format Vials

Selecting between high-capacity 50mg vials and standard research formats (such as 5mg or 10mg vials) depends on the scale and design of the laboratory protocol. High-density 50mg formats offer lower unit-mass costs and high consistency for automated liquid handling platforms running hundreds of assay wells simultaneously. However, for smaller rodent cohorts or intermittent pilot studies, large vials carry a higher risk of waste if aliquots expire before consumption.

Standard format vials—such as those available across our broader all peptides catalog—provide greater flexibility for varied experimental designs, shorter exposure windows post-reconstitution, and reduced dependency on long-term freezer storage facilities. Evaluating lab workflow throughput ensures the optimal vial specification is selected.

Comparative Peptide Profiles in GH Secretagogue Research

Within preclinical research into growth hormone dynamics and tissue repair, several distinct peptide classes are evaluated for receptor potency and half-life. While CJC-1295 combined with Ipamorelin offers a dual GHRHR/GHSR-1a targeted profile, investigators often compare these mechanisms to related single-target or multi-target agents. For instance, GHRP-2 exhibits potent GHSR-1a agonism but demonstrates greater prolactin and cortisol stimulation in animal models compared to the highly selective Ipamorelin. Meanwhile, shorter-acting GHRH analogs like Sermorelin present rapid clearance kinetics suitable for transient receptor mapping, whereas extended GHRH structures like Tesamorelin display specialized affinity profiles often studied in lipid metabolic pathways. Understanding these biochemical distinctions assists researchers in selecting the correct comparative controls.

In Vitro and Preclinical Application Frameworks

In vitro models utilizing pituitary cell lines rely on CJC-1295 + Ipamorelin blends to investigate intracellular signaling cascades, specifically cAMP elevation and calcium influx dynamics. These studies assist in mapping secretagogue sensitivity under varying metabolic environments.

In preclinical animal models, researchers evaluate this dual compound to measure systemic IGF-1 upregulation, muscle protein synthesis markers, bone mineral density parameters, and cellular tissue repair rates following induced damage. Standardizing concentration math and working storage ensures reproducible plasma level elevation across treatment cohorts.

Institutional Sourcing and PX1 Research Standards

Securing consistent research compounds requires transparent sourcing and robust quality infrastructure. PX1 Research manufactures all compounds in USA-based, GMP-compliant facilities under strict quality management systems. Orders are fulfilled rapidly with same-day shipping (Monday through Friday) operating out of dual distribution hubs in California and Arizona.

For high-volume laboratories, university departments, and institutional buyers seeking bulk procurement or specialized custom manufacturing, PX1 Research provides dedicated support through our wholesale lab account portal. Our commitment to strict batch testing, physical chemical verification, and non-hyped scientific communication ensures your research is built on verifiable chemical foundation.